Expanded recall for Franck's Compounds

Share this article:

The FDA is notifying all physicians and healthcare organizations of the recall of all sterile products sold by Franck's Compounding Pharmacy since November 2011 due to the possibility of lack of sterility.

In March 19, 2012, FDA received reports of fungal endophthalmitis in patients who were given Brilliant Blue G (BBG), supplied by Franck's Pharmacy, during eye surgeries. In April 20, 2012, FDA received reports of eye infections in patients who were given injections of Franck's drug products containing triamcinolone acetonide during eye surgery.

An active investigation by the CDC and FDA is ongoing at this time. FDA advises that any product received from Franck's since November 2011 not be used.

For more information visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305592.htm.

Share this article:
You must be a registered member of Clinical Advisor to post a comment.

More in Web Exclusives

FDA warns against laparoscopy for uterine fibroids

FDA warns against laparoscopy for uterine fibroids

Laparoscopic power morcellation pose a cancer risk, agency says.

Less dietary salt likely key to drop in stroke deaths

Less dietary salt likely key to drop in ...

Substantial decreases observed in blood pressure, ischemic heart disease mortality also seen.

Diagnostic errors affect 1 in 20 U.S. adults

Diagnostic errors affect 1 in 20 U.S. adults

About half of diagnostic errors are potentially harmful.